1[1]Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death[J]. J Exp Med, 1995,182(2) :367-377.
2[2]Wallace DC. A mitochondrial paradigm for degenerative diseasesand ageing[J]. Novartis Found Symp, 2001,235:247-263.
3[3]Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor [J]. Nature, 1999,397:441-445.
4[4]Chunying Du, Min Fang, Yucheng Li, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J ]. Cell,2000,102: 33-42.
5[5]Jacobson MD, Raff MC. Programmed cell death and Bcl-2 protection in very low oxygen[J ]. Nature, 1995, 374: 814-816.
6[6]Karlseder J, Broccoli D, Dai Y, et al. p53-and ATMdependent apoptosis induced by telomeres lacking TRF2 [J].Science, 1999,283(5406): 1321-1325.
7[7]Hengartner MO. Death cycle and Swiss army knives [J].Nature, 1997,391:441-442.
8[8]Kannan K, Amariglio N, Rechavi G, et al. DNA microarrays identification of primary and secondary target genes regulated by p53 [J]. Oncogene, 2001,20(18) :2225-2234.
9[9]Anne OH, Debbie L, Takashi S, et al. Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis [J]. Science, 1997,278:1305-1309.
10[10]Wang CY, Guttridge DC, Mayo MW, et al. NF-kappa B induces expression of the Bcl-2 homologue Al/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis [ J ].Mol Cell Biol, 1999,96:5923-5929.
